Advanced search

Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition.

(2001) DIABETIC MEDICINE. 18(4). p.288-294
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
CHATURVEDI, N, JH FULLER, F POKRAS, Raoul Rottiers, N PAPAZOGLOU, and LP AIELLO. 2001. “Circulating Plasma Vascular Endothelial Growth Factor and Microvascular Complications of Type 1 Diabetes Mellitus: The Influence of ACE Inhibition.” Diabetic Medicine 18 (4): 288–294.
APA
CHATURVEDI, N., FULLER, J., POKRAS, F., Rottiers, R., PAPAZOGLOU, N., & AIELLO, L. (2001). Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition. DIABETIC MEDICINE, 18(4), 288–294.
Vancouver
1.
CHATURVEDI N, FULLER J, POKRAS F, Rottiers R, PAPAZOGLOU N, AIELLO L. Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition. DIABETIC MEDICINE. 2001;18(4):288–94.
MLA
CHATURVEDI, N, JH FULLER, F POKRAS, et al. “Circulating Plasma Vascular Endothelial Growth Factor and Microvascular Complications of Type 1 Diabetes Mellitus: The Influence of ACE Inhibition.” DIABETIC MEDICINE 18.4 (2001): 288–294. Print.
@article{169197,
  author       = {CHATURVEDI, N and FULLER, JH and POKRAS, F and Rottiers, Raoul and PAPAZOGLOU, N and AIELLO, LP},
  issn         = {0742-3071},
  journal      = {DIABETIC MEDICINE},
  language     = {eng},
  number       = {4},
  pages        = {288--294},
  title        = {Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition.},
  volume       = {18},
  year         = {2001},
}

Web of Science
Times cited: